MedInvent
Private Company
Funding information not available
Overview
MedInvent is a commercial-stage medical device company addressing a critical need in obstetrics: the precise execution of episiotomies to prevent severe perineal tears (OASIS). Its single, patented product, the EPISCISSORS-60™, is a physical guide that ensures clinicians can consistently achieve the angle recommended by global bodies like RCOG and FIGO. The device has achieved significant adoption in the UK's NHS and internationally, with multiple published studies and systematic reviews demonstrating a 50-60% relative reduction in OASIS rates, leading to substantial clinical benefits and cost savings for healthcare systems.
Technology Platform
Patented surgical scissors with an integrated fixed-angle (60-degree) physical guide to standardize and accurately perform mediolateral episiotomies, eliminating operator variability.
Opportunities
Risk Factors
Competitive Landscape
Competes primarily against standard, non-guided episiotomy scissors which are ubiquitous and low-cost. The value proposition is not against a direct device competitor, but against variable human technique. Barriers to entry include the company's strong IP, extensive clinical evidence base, and entrenched adoption in a major reference market (NHS).